REBECCA LAYMAN: Open Payments
NPI 1629508577 · NEW CASTLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$662 in 27 payments from 5 companies in 2025. Trend: 2023 $15 · 2024 $208 · 2025 $662
Food & beverage: $662
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 7 | $184 |
| Boston Scientific Corporation | 2 | $183 |
| ABBVIE INC. | 11 | $162 |
| Abbott Laboratories | 5 | $92 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $41 |
Products named: Intracept, INCEPTIV, BOTOX, INTELLIS ADAPTIVESTIM, PROCLAIM, QULIPTA, JOURNAVX, ETERNA.
Industry payments across IN — which companies pay providers there.
